Taking Stock
GW's Gover on Cannabis-Derived Drug for Rare Epilepsy (Audio)
- Autor: Vários
- Narrador: Vários
- Editora: Podcast
- Duração: 0:08:45
- Mais informações
Informações:
Sinopse
(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. GUEST: Justin Gover, CEO of GW Pharmaceuticals, on the drug pipeline for the UK- based company which has been developing drug treatments derived from cannabis for decades.
